GlassScriptPhysician profile
William B Plauche
NPI 1871535674
$19,607.97
in general payments reported to CMS, 2019-2025
32 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $999 · 2020: $1,920 · 2021: $851 · 2022: $524 · 2023: $1,089 · 2024: $1,972 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $3,443 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $900 · Honoraria: $25.59 · Education: $20.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,925.00 |
| Food and Beverage | $3,443.48 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $900.00 |
| Honoraria | $25.59 |
| Education | $20.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $13,357.33 | 2022-2025 | Envista Mx60 Iol, Ic-8 Apthera Iol, Envista Envy Iol |
| Glaukos Corporation | $1,244.46 | 2019-2025 | Idosetr, Idose, Istent Infinite |
| Ivantis, INC | $1,066.85 | 2019-2020 | |
| Alcon Vision LLC | $633.13 | 2019-2024 | Clareon, Ngenuity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $629.00 | 2019-2021 | |
| Biotissue Holdings INC. | $381.87 | 2021-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $292.50 | 2019-2024 | Tecnis Iol |
| Rxsight INC | $251.50 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Sight Sciences, INC. | $211.03 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ocular Therapeutix, INC. | $198.48 | 2020-2021 | |
| Ellexiscience | $191.85 | 2019 | |
| Notal Vision, INC. | $150.09 | 2022 | |
| Abbvie INC. | $148.21 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $118.71 | 2019-2025 | Eylea Hd, Eylea |
| Bausch Health US, LLC | $102.44 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $84.69 | 2019-2020 | |
| Beaver-Visitec International, INC. | $82.03 | 2019-2022 | |
| Lensar, INC. | $73.75 | 2020 | |
| Allergan, INC. | $68.92 | 2020 | |
| Dompe US, INC. | $52.96 | 2025 | Oxervate |
| Harrow Eye, LLC | $38.29 | 2025 | Vevye |
| Horizon Therapeutics Plc | $35.15 | 2021-2022 | |
| Nova Eye, INC. | $31.64 | 2025 | |
| Genentech USA, INC. | $26.05 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $25.93 | 2023 | Exparel |
| Carl Zeiss Meditec, INC. | $19.74 | 2019 | |
| Tearlab Corp | $18.41 | 2024 | Scoutpro Osmolarity System |
| New World Medical,INC. | $17.31 | 2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Carl Zeiss Meditec USA, INC. | $15.20 | 2024 | |
| Rayner Intraocular Lenses Limited | $14.14 | 2025 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Aerie Pharmaceuticals, INC. | $14.08 | 2021 | |
| Omeros Corporation | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Plauche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.